Evidence map›Paper›PMID 39580546›Full record

ArticleNature communications2024

Impact of easing COVID-19 restrictions on antibiotic usage in Eastern China using wastewater-based epidemiology.

Jinxin Zang, Lufang Jiang, Yingying Wang, Yue Chen, Chaowei Fu, Barbara Kasprzyk-Hordern, Na Wang, Qingwu Jiang, Helen Lambert

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jinxin ZangKey Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, 200032, China.ORCID 0000-0001-5810-7968
Lufang JiangKey Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, 200032, China.
Yingying WangKey Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, 200032, China.
Yue ChenSchool of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, K1N 6N5, Canada.
Chaowei FuKey Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, 200032, China.ORCID 0000-0003-0966-8552
Barbara Kasprzyk-HordernDepartment of Chemistry, Faculty of Science, University of Bath, Bath, BA2 7AY, UK. b.kasprzyk-hordern@bath.ac.uk.ORCID 0000-0002-6809-2875
Na WangKey Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, 200032, China. na.wang@fudan.edu.cn.ORCID 0000-0003-0806-4247
Qingwu JiangKey Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, 200032, China.ORCID 0000-0001-8921-3317
Helen LambertPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 1TH, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus Disease 2019 (COVID-19) emerged in December 2019, prompting the implementation of a "zero-COVID" policy in Mainland China. The easing of this policy in December 2022 led to a surge in COVID cases, which was believed to significantly increase antibiotic usage, potentially due to antibiotic misuse or increased coinfections. Our study aimed to compare antibiotic consumption and patterns before and after this policy adjustment. We utilised wastewater-based epidemiology (WBE) to analyse antibiotic levels in samples collected from five wastewater treatment plants in Eastern China during January and February of 2021 and 2023. 27 antibiotics were quantified using ultra-high performance liquid chromatography coupled with triple quadrupole tandem mass spectrometry (UPLC-MS/MS) and analysed via WBE, with the resulting estimates compared with catchment-specific prescription data. 23 antibiotics were detected in wastewater samples, with a substantial increase in usage in 2023 (ranging from 531% to 3734%), consistent with prescription data. Here, we show a significant rise in antibiotic consumption during the COVID-19 surge and this underscores the need for further investigation into the impacts of inappropriate antibiotic use in China.

Indexed as

Anti-Bacterial AgentsCOVID-19SARS-CoV-2WastewaterWastewater-Based Epidemiological MonitoringChinaHumansTandem Mass SpectrometryAnti-Bacterial AgentsWastewater

Identifiers

PMID39580546
PMCPMC11585548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.